Citron ML - Search Results

1

Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B.

Yogelzang NJ, Herndon JE 2nd, Cirrincione C, Harmon DC, Antman KH, Corson JM, Suzuki Y, Citron ML, Green MR. Yogelzang NJ, et al. Among authors: citron ml. Cancer. 1997 Jun 1;79(11):2237-42. doi: 10.1002/(sici)1097-0142(19970601)79:11<2237::aid-cncr23>3.0.co;2-w. Cancer. 1997. PMID: 9179072 Clinical Trial.

2

Phase II trial of high-dose 24-hour continuous intravenous 5-fluorouracil for advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.

Citron ML, Modeas C, Propert K, Goutsou M, Green MR. Citron ML, et al. Cancer Invest. 1992;10(3):215-9. doi: 10.3109/07357909209032763. Cancer Invest. 1992. PMID: 1316201 Clinical Trial.

3

Patient-controlled analgesia for cancer pain: a long-term study of inpatient and outpatient use.

Citron ML, Kalra JM, Seltzer VL, Chen S, Hoffman M, Walczak MB. Citron ML, et al. Cancer Invest. 1992;10(5):335-41. doi: 10.3109/07357909209024792. Cancer Invest. 1992. PMID: 1393684 Clinical Trial.

4

Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain.

Citron ML, Kaplan R, Parris WC, Croghan MK, Herbst LH, Rosenbluth RJ, Reder RF, Slagle NS, Buckley BJ, Kaiko RF. Citron ML, et al. Cancer Invest. 1998;16(8):562-71. doi: 10.3109/07357909809032886. Cancer Invest. 1998. PMID: 9844616 Clinical Trial.

5

Clearance of continuous intravenous morphine for severe cancer pain.

Citron ML, Reynolds JR, Lin WN, Frade PD, Schemansky M, Cohen MH, Krasnow SH, Johnston-Anderson A, Seltzer VL. Citron ML, et al. Drug Intell Clin Pharm. 1987 Dec;21(12):981-5. doi: 10.1177/106002808702101211. Drug Intell Clin Pharm. 1987. PMID: 3428164

6

An active chemotherapy regimen for squamous cell lung cancer.

Cohen MH, Johnston-Early A, Citron ML, Krasnow SH, Fossieck BE Jr. Cohen MH, et al. Among authors: citron ml. Cancer Treat Rep. 1984 Mar;68(3):475-9. Cancer Treat Rep. 1984. PMID: 6200219

7

Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.

Citron ML, Herman TS, Vreeland F, Krasnow SH, Fossieck BE Jr, Harwood S, Franklin R, Cohen MH. Citron ML, et al. Cancer Treat Rep. 1985 Jan;69(1):109-12. Cancer Treat Rep. 1985. PMID: 2981616 Clinical Trial.

8

Lung cancer, tuberculin reactivity, and isoniazid.

Alhashimi MM, Citron ML, Fossieck BE Jr, Steinberg SM, Johnston-Early A, Krasnow SH, Cohen MH. Alhashimi MM, et al. Among authors: citron ml. South Med J. 1988 Mar;81(3):337-40. doi: 10.1097/00007611-198803000-00013. South Med J. 1988. PMID: 2831628

9

5-Fluorouracil pharmacokinetics in patients with metastatic colorectal carcinoma after high-dose leucovorin.

Stein TA, Burns GP, Bailey B, Citron ML. Stein TA, et al. Among authors: citron ml. Cancer Invest. 1994;12(4):375-8. doi: 10.3109/07357909409038225. Cancer Invest. 1994. PMID: 8032956

10

Combined therapy for stage III-IV head and neck cancer: preliminary results.

Krasnow SH, Cohen MH, Johnston-Early A, Citron ML, Fossieck BE Jr, Mauk CM, Yenson A, Banda FP, Lunzer S, deFries HO. Krasnow SH, et al. Among authors: citron ml. J Clin Oncol. 1984 Jul;2(7):804-10. doi: 10.1200/JCO.1984.2.7.804. J Clin Oncol. 1984. PMID: 6737021

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters